Novo Nordisk A/S
CPSE:NOVO B
kr 237,45
kr-0,45 (-0,19%)
237,45 kr
kr-0,45 (-0,19%)
End-of-day quote: 03/20/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
20,54%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
-8,84%
Outlook 12/26
W
66,88%
Margin of safety
T
26,76%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
20,65%
Revenue growth 5Y
20,44%
Price growth 5Y
12,12%
Market Cap
kr1.054,52 B
Long-Term Debt
kr110,37 B
Quarterly earnings
05/07/2026 (E)
Dividend
kr11,68
Dividend Yield
4,92%
Industry
Country
ISIN Number

Novo Nordisk A/S Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr301,00
26.76%
26.76
Last Update: 03/21/2026
Analysts: 22

Highest Price Target kr444,00

Average Price Target kr301,00

Lowest Price Target kr175,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Novo Nordisk A/S
CPSE:NOVO B
30,49% 12,12% 18,36% 20,54% 5/6 -8,84% 66,88% 26,76% DOWN
×